您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Antibodies

Anti-Human CD197 (CCR7) Antibody

Anti-Human CD197 (CCR7) Antibody

英诺赛图(InnoCyto)的 Anti-Human CD197 (CCR7) Antibody(克隆 197AR2a) 为大鼠源 IgG2a 单克隆抗体,靶向 CD197(别名 CCR7 等),Purified 标记,适用于流式细胞术。提供 100 μg、500 μg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。

生物试剂 供应商 上海英诺赛图 ↗ 型号 110901 更新 2026-11-12
参考价格区间
¥1,085
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 Anti-Human CD197 (CCR7) Antibody(克隆 197AR2a) 为大鼠源 IgG2a 单克隆抗体,靶向 CD197(别名 CCR7 等),Purified 标记,适用于流式细胞术。提供 100 μg、500 μg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

107301 | 100 μg | ¥1,085

107302 | 500 μg | ¥2,983

110901 | 100 μg | ¥1,085

110902 | 500 μg | ¥2,983

Product Details

Regulatory Status|RUO

Protein Concentration|0.5 mg/mL

Recommended Usage|For flow cytometric staining, it is recommended to use less than 0.1 µg of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application

See All Formats|Clone 197AR2a

Background Information

CD197, also known as CCR7 (C-C chemokine receptor type 7), is a G protein–coupled receptor (GPCR) that plays a crucial role in the organization and trafficking of immune cells. This receptor primarily regulates the migration of T cells, B cells, and dendritic cells to lymphoid tissues, thus coordinating immune surveillance and adaptive immune responses. CCR7 is a typical seven-transmembrane GPCR composed of approximately 378 amino acids. It features an extracellular N-terminal region responsible for ligand binding, seven hydrophobic transmembrane helices, three intracellular and extracellular loops, and a cytoplasmic C-terminal domain that interacts with intracellular signaling molecules. Upon ligand binding, CCR7 activates heterotrimeric G proteins that trigger downstream signaling cascades, including PI3K and MAPK pathways, influencing cell migration, survival, and activation. CCR7 primarily binds two chemokines, CCL19 (ELC) and CCL21 (SLC), which are produced in the lymphoid organs and high endothelial venules. These interactions guide lymphocytes and dendritic cells to secondary lymphoid tissues by establishing chemokine gradients. CCL19 and CCL21 binding induces conformational changes in CCR7 that drive chemotaxis, adhesion, and polarization of responding cells.

Aberrant CCR7 signaling has been implicated in multiple pathological conditions. In cancer, CCR7 facilitates metastasis by directing tumor cells to lymph nodes, a common route for early dissemination. Elevated CCR7 expression is particularly noted in breast cancer, melanoma, and colorectal carcinoma. In autoimmune disorders such as rheumatoid arthritis and multiple sclerosis, overexpression of CCR7 contributes to the mislocalization and activation of immune cells that perpetuate inflammation. Moreover, certain pathogens manipulate CCR7 pathways to evade immune detection.

Due to its central role in immune cell trafficking, CCR7 is an attractive therapeutic target. Strategies to modulate CCR7 activity include the development of small-molecule inhibitors, neutralizing antibodies, and chemokine decoys to block pathological migration. Conversely, enhancing CCR7 signaling may improve vaccine efficacy and immune reconstitution by optimizing dendritic cell and T cell homing. Ongoing research continues to explore the receptor’s potential in immunotherapy, cancer metastasis prevention, and autoimmune disease management.

Data Sheets

Human PBMC was stained with Purified Anti-Human CD197 clone 197AR2a (color-filled histogram) or an isotype control (gray histogram), followed by PE anti-rat IgG 2nd antibody.

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格100 μg
Clone197AR2a
ApplicationFlow Cytometry
ReactivityHuman
FormatPurified
Target NameCD197, CCR7, BLR2, CDw197, EBI1, CMKBR7
IsotypeRat IgG2a
Antibody TypeMonoclonal
Regulatory StatusRUO
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
Protein Concentration0.5 mg/mL
Storage&HandlingThe antibody solution should be stored between 2°C and 8°C
RRIDAB_3738956
目录价¥1,085

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). Anti-Human CD197 (CCR7) Antibody(110901)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/anti-human-cd197-ccr7-antibody-110901.html.
TeleVM. (2026, November 12). Anti-Human CD197 (CCR7) Antibody(110901). 产品目录. https://www.suprotek.cn/products/item/anti-human-cd197-ccr7-antibody-110901.html
@misc{biocsp_item_anti_human_cd197_ccr7_antibody_110901,
  title        = {Anti-Human CD197 (CCR7) Antibody(110901)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/anti-human-cd197-ccr7-antibody-110901.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

Anti-Human CD197 (CCR7) Antibody

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。